Skip to Main Content
Back to News

FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings

None

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Tuesday, May 13th. The company reported earnings of -$0.04 per share, beating estimates of -$0.09 by $0.05. The company also reported revenue of $8,750,000, beating estimates of $8,344,620 by $405,380.

You can see Quiver Quantitative's $FENC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

FENNEC PHARMACEUTICALS Insider Trading Activity

FENNEC PHARMACEUTICALS insiders have traded $FENC stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $FENC stock by insiders over the last 6 months:

  • ROSTY RAYKOV has made 0 purchases and 8 sales selling 52,431 shares for an estimated $325,730.
  • CHRIS A RALLIS has made 0 purchases and 2 sales selling 7,595 shares for an estimated $47,439.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

FENNEC PHARMACEUTICALS Hedge Fund Activity

We have seen 34 institutional investors add shares of FENNEC PHARMACEUTICALS stock to their portfolio, and 28 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles